Sfoglia per AUTORE
VERMORKEN J
Collezione AO Cuneo

  

Items : 3

Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Oct 1;28(10):2526-2532. doi: 10.1093/annonc/mdx344.
2017
AO Cuneo

Cohen EEW; Licitra LF; Burtness B; Fayette J; Gauler T; Clement PM; Grau JJ; Del Campo JM; Mailliez A; Haddad RI; Vermorken JB; Tahara M; Guigay J; Geoffrois L; Merlano MC; Dupuis N; Krämer N; Cong XJ; Gibson N; Solca F; Ehrnrooth E; Machiels JH;

Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis. in The oncologist / Oncologist. 2016 Jan;21(1):59-71. doi: 10.1634/theoncologist.2015-0246. Epub 2015 Dec 28.
2016
AO Cuneo

Vanderveken OM; Szturz P; Specenier P; Merlano MC; Benasso M; Van Gestel D; Wouters K; Van Laer C; Van den Weyngaert D; Peeters M; Vermorken J;

Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2015 Aug;95(2):191-213. doi: 10.1016/j.critrevonc.2015.03.003. Epub 2015 Mar
2015
AO Cuneo
AOU Città della Salute di Torino

Vermorken JB; Raber-Durlacher J; Bernier J; Cascio A; Pergolizzi S; Buglione M; Caspiani O; Denaro N; Moretto F; Licitra L; Merlano MC; Ghi MG; Merlotti A; Musso S; De Sanctis V; Bacigalupo A; Crippa F; Bossi P; Numico G; Russi EG; Mirabile A; Murphy B; Ranieri MV; Dellinger RP;